Phase 2 Trial of Belzupacap Sarotalocan (Bel-Sar, AU-011), a Targeted Therapy for Choroidal Melanoma via Suprachoroidal Administration

  • Amy C. Schefler, MD FACS FASRS
  • Video
  • Published 2023

See more